Literature DB >> 7068937

Phenobarbital pharmacokinetics and bioavailability in adults.

E Nelson, J R Powell, K Conrad, K Likes, J Byers, S Baker, D Perrier.   

Abstract

The pharmacokinetics and bioavailability of phenobarbital were examined in six healthy adult subjects after a 2.6 mg/kg intravenous and a 2.9 mg/kg oral dose. Serum concentrations of phenobarbital were followed by means of a high pressure liquid chromatographic assay for 21 days after drug administration. After the intravenous dose, the mean distribution half-life was 0.18 hour and the mean elimination half-life was 5.8 days. Mean total body clearance and mean renal clearance were 3.0 ml/hr/kg and 0.8 ml/hr/kg, respectively. The apparent volume of distribution was 0.60 liter/kg. After administration of phenobarbital tablets, the maximum phenobarbital serum concentration was 5.5 mg/liter at 2.3 hours after the dose. Adjusted absolute availability of phenobarbital from the tablets studied was 94.9 per cent (range 81-111.9 per cent). The elimination half-life averaged 5.1 days for the oral dose. There was no evidence of autoinduction of phenobarbital elimination over the study period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068937     DOI: 10.1002/j.1552-4604.1982.tb02662.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  10 in total

Review 1.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review.

Authors:  Drayton A Hammond; Jordan M Rowe; Adrian Wong; Tessa L Wiley; Kristen C Lee; Sandra L Kane-Gill
Journal:  Hosp Pharm       Date:  2017-07-17

3.  Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.

Authors:  Katarina Vučićević; Marija Jovanović; Bojana Golubović; Sandra Vezmar Kovačević; Branislava Miljković; Žarko Martinović; Milica Prostran
Journal:  Eur J Clin Pharmacol       Date:  2014-11-09       Impact factor: 2.953

Review 4.  Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.

Authors:  Masumeh Ghazanfarpour; Mona Najaf Najafi; Nasibeh Roozbeh; Mohamadghasem Etemadi Mashhadi; Atefeh Keramat-Roudi; Bruno Mégarbane; Aristidis Tsatsakis; Mohammad Mobin Miri Moghaddam; Ramin Rezaee
Journal:  Daru       Date:  2019-05-15       Impact factor: 3.117

Review 5.  Mechanical Ventilation in Patients with Traumatic Brain Injury: Is it so Different?

Authors:  Shaurya Taran; Sung-Min Cho; Robert D Stevens
Journal:  Neurocrit Care       Date:  2022-09-07       Impact factor: 3.532

6.  Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro.

Authors:  A Dash; M B Simmers; T G Deering; D J Berry; R E Feaver; N E Hastings; T L Pruett; E L LeCluyse; B R Blackman; B R Wamhoff
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-13       Impact factor: 4.249

Review 7.  Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.

Authors:  E Yukawa
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 8.  Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy.

Authors:  Sima I Patel; Angela K Birnbaum; James C Cloyd; Ilo E Leppik
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

9.  Physiologically based pharmacokinetic modeling for dose optimization of quinine-phenobarbital coadministration in patients with cerebral malaria.

Authors:  Teerachat Sae-Heng; Rajith Kumar Reddy Rajoli; Marco Siccardi; Juntra Karbwang; Kesara Na-Bangchang
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-11-23

10.  Assessment of porphyrogenicity of drugs and chemicals in selected hepatic cell culture models through a fluorescence-based screening assay.

Authors:  Christopher D Ma; Cynthia G Van Horn; Meimei Wan; Colin Bishop; Herbert L Bonkovsky
Journal:  Pharmacol Res Perspect       Date:  2022-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.